Author: Marie Jones

In anticipation of Centrality’s staking support, Moonstake has successfully launched the world’s first CENNZ validator. Moonstake will be the first wallet in the world to support CENNZ staking. Moonstake successfully completed the API connection to CENNZnet and has been preparing for development for staking support. Moonstake’s wallet supports holding, sending and receiving CENNZ, Centrality’s native token and it will soon provide staking functions. Once staking support is available, Moonstake users will be able to stake through the Moonstake wallet and receive CPAY as staking rewards. Moonstake started in the staking business last year with the aim to create the largest…

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the “Strategic Investment”), in Bionomics Limited (“Bionomics”) (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders. In addition, Cedar Clinical Research (“CCR”), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ Phase IIb trial examining BNC210. BNC210…

Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Iterion Therapeutics, Inc., a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, today announced an exclusive collaboration and license agreement for the development and commercialization of tegavivint in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China. Tegavivint is a potent and selective inhibitor of nuclear Beta-catenin that works through binding to TBL1 (Transducin Beta-like Protein One), a downstream target in the Wnt-signaling pathway. Iterion is pursuing the development of Tegavivint for the treatment of cancers where…

ZALL Group, Asia’s leading B2B e-commerce group, has officially opened its first overseas all-in-one Chinese bookstore on 8 February 2021 that is situated right in the heart of Orchard Road at Wheelock Place. The bookstore comprises of a cafe, art gallery and craft store, as well as event and outdoor spaces. Aspiring to create an all-in-one lifestyle experience, ZALL Bookstore seeks to create the perfect quintessential conducive environment for like-minded individuals who are passionate about Chinese culture, literature and arts to congregate and interact. “Perfect for enthusiasts who are keen to learn more about Chinese culture, ZALL Bookstore creates a…

On February 8, Joy Spreader published an announcement to alert that its results in 2020 would achieve substantial growth over 2019. According to the announcement, the Company’s revenue in 2020 is expected to range from approximately HK$880 million to HK$920 million, an increase ranging from around 63.6% to 71.0% as compared to 2019. The gross profit is expected to range from roughly HK$260 million to HK$300 million, an increase ranging from approximately 95.5% to 125.6% as compared to 2019. The profit before exchange gains and losses is expected to range from roughly HK$170 million to HK$200 million, representing an increase…

Apollomics licenses worldwide rights (ex-China, Hong Kong and Taiwan) to develop and commercialize EO1001 EO1001 is an irreversible, pan-erbB inhibitor of EGFR (ErbB1), HER2 (ErbB2) and HER4 (ErbB4) Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Edison Oncology Holding Corp., today announced that Apollomics has been granted worldwide rights, excluding China, Hong Kong and Taiwan, for the development and commercialization of EO1001. EO1001 is a protein tyrosine kinase inhibitor (TKI) that has demonstrated irreversible inhibition of EGFR (ErbB1), HER2 (ErbB2) and HER4 (ErbB4) as a single agent. “We are…

Intco Medical (300677:CH), a leading Shenzhen listed personal protective equipment (PPE) provider, announced on 24 January a positive profit alert for the 12 months ended December 31, 2020. The company expected profit attributable to shareholders to range from RMB6,800 to RMB7,300 million during the review period, representing a year-on-year increase of 3713.45% to 3993.85%. The sharp jump in earnings was driven by surging global demand for disposable protective gloves amid the COVID-19 pandemic. This backdrop spearheaded significant increase in the prices of the company’s disposable protective gloves, thereby boosting both sales revenue and gross profit margin. The company also passed…

Alphabit Fund Deploys Initial Investment into Stratis Protocol and Initiates Coverage Blockchain as a Solution (BaaS) service provider Stratis makes decentralized adoption easier for any firm with its innovative products designed to fit seamlessly with legacy operations, by allowing companies access to the Stratis blockchain via the widely-used C# programming language. The platform allows seamless running of smart contracts, multiple sidechains, and houses a full-scale ICO platform. Alphabit, a USD 1 billion AUM fund and one of the world’s first regulated digital asset investment funds focused on delivering turn-key solutions and assisting projects with end-to-end partnerships, enters into this venture…

Shougang Concord Century Holdings Limited (HKG:103) is pleased to announce that, based on its preliminary assessment of the unaudited consolidated financial statements of the Group for the year ended 31 December 2020, the Group expects a profit after tax of not less than HK$130 million, at least 20% more than that of HK$108 million for the previous year. Such increase was primarily attributable to the improvement of gross profit margin arisen from the decrease in production costs and the reduction in finance costs. Shougang Century is primarily engaged in manufacturing of steel cords for radial tyres, sawing wires and other…

With people in Asia and around the world set to celebrate Lunar New Year, CropLife Asia called for greater appreciation of regional growers and their critical contributions to food production – helping ensure food security across Asia and making available many of the ingredients to dishes enjoyed during this festive time of year. “Lunar New Year is a time when we reflect, spend more time with friends and family, and enjoy the delicious foods of the season,” said Dr. Siang Hee Tan, CropLife Asia Executive Director. “In the midst of the ongoing global pandemic, it all takes on greater meaning.…

PARIS & TOKYO, Feb 9, 2021 – JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand, and Worldline, a European leader in the payments and transactional services industry, announce the expansion of their partnership. This established relationship has pivoted to support both the exchange of global ecommerce and the growth of JCB Contactless enablement across Europe. Previously, the two brands coordinated to support digital shopping outside of Europe and worked to enable JCB Contactless in regions such as Switzerland, Austria, Belgium, Luxembourg, Slovenia, Belgium, and Poland. Now, their collaboration will make room…

Confident in plan to boost capacity with no labor shortage this year Sri Trang Gloves (Thailand) PCL (SET: STGT) enacts protective measures against the new Covid-19 outbreak – infection screening, weekly disinfectant spraying, mask wearing, and social distancing. Foreign workers are required to have work permits and passports. Additionally, Reduced congestion and increased hygienic housing are to be provided for employees to reduce risks. No labor shortages are expected while four new manufacturing plants are scheduled to open this year. Ms. Jarinya Jirojkul, Chief Executive Officer of STGT, a global producer of latex and nitrile gloves, reports that since the…

 Humanitarian crisis averted as MSC arranges relief for seafarers stuck off China’s coast since September  Bulk carrier ANASTASIA’s crew to disembark on 10 February in Japan, before ship resumes service MSC will continue to monitor seafarers’ health and well-being while arranging repatriation Following months of repeated appeals by MSC Mediterranean Shipping Company to allow a change of crew on ANASTASIA, a cargo ship which had been stuck off the coast of China since September, MSC has effectively resolved the matter, avoided a humanitarian crisis onboard and mitigated the related safety risks. MSC, which maintains the vessel and organises its crew,…

In response to the Executive Order titled Promoting the Use of Trustworthy Artificial Intelligence in the Federal Government, the Government Blockchain Association, GBA, is pleased to announce that we are launching the AI for Government Community, led by Mr. Oki Mek, the Chief Artificial Intelligence Officer, (CAIO), for US Health and Human Services, (HHS). Mr. Mek, along with Jose Arrieta, Former CIO at HHS, developed Accelerate, the first blockchain-based program in the Federal government to get an authority-to-operate. This program was purported to save HHS $30 million over five years, according to MeriTalk, 2/11/2020. Mr. Mek’s leadership will be instrumental…

TOKYO, Feb 8, 2021 – Showa Denko (SDK; TOKYO:4004) has acquired 50% ownership in AMI Automation, headquartered in Monterrey, Mexico, effective on 5th February 2021. AMI Automation provides fully integrated automation and control solutions to a wide range of industries. Showa Denko has an option to acquire the remaining 50% of AMI within 5 years. AMI, through its Meltshop Solutions division, provides electrode regulation systems and EAF optimization services to improve operating efficiencies, while its Industrial Systems division is an automation and control solution provider for a wide range of industries around the world. AMI’s electrode regulation systems are utilized…

HONG KONG, Feb 8, 2021 – (ACN Newswire) – Central China New Life Limited (Stock Code: 9983.HK) issued earlier a positive profit alert on its 2020 annual results in which it forecast the company’s net profit to increase by no less than 80%. The Company’s strong performance, which exceeded market expectations, subsequently earned “Buy” or “Overweight” ratings from different securities houses. The price targets issued by securities houses ranged from HKD11.2 to HKD16.47, indicating potential upside of between 47% and 88% compared to the stock’s closing price of HKD7.6 last Friday. Everbright Securities was the most upbeat among different securities houses as it significantly…

Blockpass, the pioneer of On-chain KYC(TM), is excited to announce its latest partner, Modefi, in what is another step towards providing security and trust for Oracle solutions and blockchain technology. In this new partnership, Blockpass will be providing its revolutionary KYC services to the company as Modefi seeks to create truly decentralized, secure and precise oracle solutions. This integration comes just as Modefi prepares for its token offering on the 10th of February 2021, which will take place on the TrustSwap Launchpad. As a Decentralized Aggregated Oracle, Modefi facilitates fully trustless and decentralized off-chain data, on chain, in its mission…

JBM (Healthcare) Limited (HKG:2161), a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries, started trading today on the Main Board of The Stock Exchange of Hong Kong Limited (“SEHK”) under stock code 2161. As a subsidiary of Jacobson Pharma Corporation Limited (HKG:2633), JBM Healthcare is a unique field player with drug expertise and ethical heritage that prioritises product efficacy and quality to meet consumers’ healthcare needs. As a leading healthcare brand operator in Hong Kong, the Group carried a total of 20 principal brands, including 11 third-party brands and 9…

On February 1, China Medical System (0867.HK) announced that its subsidiary had acquired Luqa Ventures Co., Limited (“Luqa”), a dermatology specialty company. This acquisition expanded its product portfolio to include Luqa’s dermatology products and marked the first foray into the medical aesthetic industry for China Medical System. Why medical aesthetics? What is the significance of this acquisition? 1. Consolidating the Skin Management Business and Entering the Medical Aesthetic Market: Acquiring Luqa to Explore a New Growth Engine According to its official website, established in 2010, Luqa is an innovative enterprise with skin treatment and medical aesthetic solutions as its core business. Its founder,…

Pacific Green Technologies, Inc. (OTCQB:PGTK)) announces the appointment of Peter Rossbach as Non-Executive and Independent Director, effective February 1st, 2021. Peter Rossbach has worked in the renewable power sector since 1985 starting with Standard & Poor rating renewable projects bonds in California. Peter moved to Catalyst Energy, a developer of hydro and cogeneration projects before becoming VP of Project Finance for Mitsui Bank, specializing in structured debt for US based wind and cogeneration projects. Peter has made dozens of investments in hydro, wind and solar projects in over twelve countries creating a portfolio of in excess of 1GW. Currently Peter…